• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
concept of two individuals in a dispute
Biotech

In deal fraud dispute with Novo, KBP looks to revive heart drug

KBP could move to conduct another phase 3 trial, potentially pursuing a smaller indication with the FDA, according to a person close to the situation.
Angus Liu Apr 1, 2026 2:30am
US currency next to a ruler pen and calculator

Top 10 pharma R&D budgets of 2025

Mar 30, 2026 3:00am
Fierce Biotech43png

Scaling Radioligand Therapy: Expanding the Impact of Theranostics

Brought to you by Curium
Sleep disorder insomnia

Lilly pays $6.3B upfront for sleep disorder-focused Centessa

Mar 31, 2026 8:53am
closed shuttered shut down closed
Favicon Fierce Pharma

Iterum initiates wind-down after failure to offload antibiotic

Mar 31, 2026 2:06pm
Sad piggy bank with bandage on its side

After FDA refusal, IO Biotech surrenders to bankruptcy

Mar 31, 2026 10:17am
More News

Ambrosia scores $100M series B to advance next-gen oral GLP-1

Mar 31, 2026 10:02am

Fierce Biotech Layoff Tracker 2026: Lipella, IO, Takeda & more

Mar 31, 2026 10:00am

BMS links up with Faro to use AI to improve trial protocols

Mar 31, 2026 9:00am

Fierce Biotech Fundraising Tracker '26: Gilgamesh, Immutrin & more

Mar 31, 2026 8:45am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings